department of pharmacology st marys hospital medical school university of london norfolk place london w ipg tele phone d v iml jias il oth march dr sheldon c sommers po box alpine new jerscy usa dear charlie since rcturning to london my colleague jackic pontin and t have given morc thought t how best to capitalize upon the studics on high and low familial risk of lung cancer which are just bcing set up with henry lynch since dr lynch will be taking the trouble of mounting the field studies in various types of high and low risk cancer pedigrecs fecl strongly that wc should not miss the opportunity of establishing immortal cell lines on each of the subjects which we will study such is my conviction that i believe these studics should bc started immediately and not constrained by my move to newcastle hcrc is my proposal omaha will be recruiting subjects each phenotyped with debrisoquine in vivo they will fall into four groups of equal size sporadic lung cancers with no other canccr family history low risk sporadic lung cancers with positive cancer family history colon cancerprone families with high and low family histories these latter two typcs of pedigrec are very interesting from the following point of view that of the members f the kindreds therc is only onc known case of lung cancer immortalized ebvtransformed lymphoblastoid bcell lines will providc future resource for studying thc molecular genetics of lung cancer risk wc are already looking in cohorts with cdna probes and rplp anal for various pso polymorphisms which wc believe may bear upon lung cancer risk at rclatively small additional cost supplemented by ctr dr lynch could mail us small batches of fresh blood for bcell transformation cannot see how this should add more than about s to the cost of cach sample collection r s in but hc needs to be asked at our cnd wc shall need ms pontins salary with oncosts s for months togcther with consumable coscs for cell transformation culture and cryopreservation of s per ccll iine cf soo nih contracted out costl ie in addition we would necd to purchase liquid nitrogen dewar for storing the cell lincs s the total cost of the project for the first ycar would thus bc s profeasor o biochemical pharmacology robert l smith roader in drug metabolism john caldwell reader in pharmacogenetics jeffrey r idle lecturer in pharmacology toxicology stephen c mitchcll lecturer in pharmacology j martin elliott chief mlso lawrenco a wakile ysis toto